As the COVID-19 pandemic has highlighted the critical role of drug safety monitoring, do join expert pharmacovigilance trainers for this 2.5-day workshop, jointly organised with the World Health Organisation (WHO), the Uppsala Monitoring Centre (UMC), Health Sciences Authority (HSA), and CoRE, as part of a continuation of efforts to enhance capabilities of pharmacovigilance in South East Asia, as well as discuss the latest trends that will improve the effectiveness of drug safety monitoring.
